Company Filing History:
2 out of 628 
1 out of 806 
1 out of 1,476 
Years Active: 2014-2021
Title: Roderick Wayland Bates: Innovator in Medical Compounds
Introduction
Roderick Wayland Bates is a notable inventor based in Singapore, SG. He has made significant contributions to the field of medical research, particularly in the development of compounds for treating tuberculosis and intravascular contrast agents. With a total of 2 patents, Bates has demonstrated his commitment to advancing healthcare solutions.
Latest Patents
Bates' latest patents include innovative compounds aimed at treating tuberculosis. The first patent focuses on pyrimidine compounds and compositions that target the F-domain of F-ATP synthase. These compounds can be used in conjunction with existing treatments such as bedaquiline or Q203, enhancing the effectiveness of tuberculosis therapies. His second patent involves intravascular contrast agents, which are Gd-chelates modified to include an amino acid unit attached via a linker group. These chelates are designed for use as intravascular contrast agents in MRI, showcasing enhanced relaxivity and improved signal enhancement.
Career Highlights
Throughout his career, Roderick Wayland Bates has worked with prestigious institutions such as Nanyang Technological University and the National University of Singapore. His work in these organizations has allowed him to contribute to significant advancements in medical research and innovation.
Collaborations
Bates has collaborated with notable professionals in his field, including Gerhard Grüber and Adam Hotra. These partnerships have further enriched his research and development efforts.
Conclusion
Roderick Wayland Bates is a distinguished inventor whose work in medical compounds has the potential to impact the treatment of serious health conditions. His innovative patents and collaborations reflect his dedication to improving healthcare solutions.